Tech Company Financing Transactions

Cure Funding Round

Lerer Hippeau, Great Oaks Venture Capital and private investors participated in a $1.5 million Series A funding round for Cure. The round closed on 4/17/2023.

Transaction Overview

Company Name

Cure

Announced On

4/17/2023

Transaction Type

Venture Equity

Amount

$1,543,000

Round

Series A

Investors

Lerer Hippeau (Lead Investor)

Great Oaks Venture Capital

private investors (Kim Clijsters)

Proceeds Purpose

Cure intends to invest the new capital in faster retail expansion, growing its leadership team, acquiring new customers and developing new products, including a bulk jar option that subscriber customers have been requesting.

Company Information

Company Status

Private & Independent

Industry

Healthcare IT

Mailing Address

Pariser Platz 6a
Berlin, 10117
Germany

Phone

Undisclosed

Website

www.getcure.app

Email Address

[email protected]

Overview

CURE Group GmbH is a healthcare on-demand company with the vision to be the easiest access to healthcare services without leaving your home. Today, CURE works with a local pharmacy network and delivers medicine quickly and sustainably. CURE was founded in December 2021 by Ali El-Ali and Manuel Aberle in Berlin.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ali El-Ali

Browse more venture capital transactions:

Prev: 4/17/2023: TaxCloud venture capital transaction
Next: 4/17/2023: Perci Health venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary